Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Akeso, Inc. ( (HK:9926) ) is now available.
Akeso, Inc. has announced that its board of directors will meet on August 26, 2025, to consider and approve the interim results for the first half of the year ending June 30, 2025. This meeting is crucial as it will determine the company’s financial performance and strategic direction, impacting stakeholders and potentially influencing its market position.
The most recent analyst rating on (HK:9926) stock is a Buy with a HK$58.97 price target. To see the full list of analyst forecasts on Akeso, Inc. stock, see the HK:9926 Stock Forecast page.
More about Akeso, Inc.
Akeso, Inc. is a company incorporated in the Cayman Islands, operating in the healthcare industry. It focuses on the development and commercialization of innovative therapies and pharmaceutical products.
Average Trading Volume: 12,794,967
Technical Sentiment Signal: Buy
Current Market Cap: HK$140.5B
For detailed information about 9926 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money